Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging
Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and ra...
Ausführliche Beschreibung
Autor*in: |
Moramkar, Nimish [verfasserIn] Bhatt, Purvi [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: European polymer journal - New York, NY [u.a.] : Elsevier, 1965, 154 |
---|---|
Übergeordnetes Werk: |
volume:154 |
DOI / URN: |
10.1016/j.eurpolymj.2021.110540 |
---|
Katalog-ID: |
ELV006202462 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV006202462 | ||
003 | DE-627 | ||
005 | 20231205154444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230505s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.eurpolymj.2021.110540 |2 doi | |
035 | |a (DE-627)ELV006202462 | ||
035 | |a (ELSEVIER)S0014-3057(21)00274-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | 4 | |a 670 |q DE-600 |
084 | |a 35.80 |2 bkl | ||
100 | 1 | |a Moramkar, Nimish |e verfasserin |0 (orcid)0000-0002-0227-9856 |4 aut | |
245 | 1 | 0 | |a Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
264 | 1 | |c 2021 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. | ||
650 | 4 | |a Chitosan derivatives | |
650 | 4 | |a Chitosan nanoparticles | |
650 | 4 | |a Chitosan nanocomplexes | |
650 | 4 | |a Drug delivery | |
650 | 4 | |a Cancer, optical imaging | |
700 | 1 | |a Bhatt, Purvi |e verfasserin |0 (orcid)0000-0001-8142-8284 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European polymer journal |d New York, NY [u.a.] : Elsevier, 1965 |g 154 |h Online-Ressource |w (DE-627)300897375 |w (DE-600)1483529-0 |w (DE-576)259270830 |7 nnns |
773 | 1 | 8 | |g volume:154 |
912 | |a GBV_USEFLAG_U | ||
912 | |a SYSFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_150 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2049 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2065 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2088 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2118 | ||
912 | |a GBV_ILN_2122 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2411 | ||
912 | |a GBV_ILN_2470 | ||
912 | |a GBV_ILN_2507 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4334 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4393 | ||
936 | b | k | |a 35.80 |j Makromolekulare Chemie |
951 | |a AR | ||
952 | |d 154 |
author_variant |
n m nm p b pb |
---|---|
matchkey_str |
moramkarnimishbhattpurvi:2021----:nihitcioadrvdaohrpuisoatcned |
hierarchy_sort_str |
2021 |
bklnumber |
35.80 |
publishDate |
2021 |
allfields |
10.1016/j.eurpolymj.2021.110540 doi (DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 DE-627 ger DE-627 rda eng 670 DE-600 35.80 bkl Moramkar, Nimish verfasserin (orcid)0000-0002-0227-9856 aut Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging Bhatt, Purvi verfasserin (orcid)0000-0001-8142-8284 aut Enthalten in European polymer journal New York, NY [u.a.] : Elsevier, 1965 154 Online-Ressource (DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 nnns volume:154 GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.80 Makromolekulare Chemie AR 154 |
spelling |
10.1016/j.eurpolymj.2021.110540 doi (DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 DE-627 ger DE-627 rda eng 670 DE-600 35.80 bkl Moramkar, Nimish verfasserin (orcid)0000-0002-0227-9856 aut Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging Bhatt, Purvi verfasserin (orcid)0000-0001-8142-8284 aut Enthalten in European polymer journal New York, NY [u.a.] : Elsevier, 1965 154 Online-Ressource (DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 nnns volume:154 GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.80 Makromolekulare Chemie AR 154 |
allfields_unstemmed |
10.1016/j.eurpolymj.2021.110540 doi (DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 DE-627 ger DE-627 rda eng 670 DE-600 35.80 bkl Moramkar, Nimish verfasserin (orcid)0000-0002-0227-9856 aut Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging Bhatt, Purvi verfasserin (orcid)0000-0001-8142-8284 aut Enthalten in European polymer journal New York, NY [u.a.] : Elsevier, 1965 154 Online-Ressource (DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 nnns volume:154 GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.80 Makromolekulare Chemie AR 154 |
allfieldsGer |
10.1016/j.eurpolymj.2021.110540 doi (DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 DE-627 ger DE-627 rda eng 670 DE-600 35.80 bkl Moramkar, Nimish verfasserin (orcid)0000-0002-0227-9856 aut Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging Bhatt, Purvi verfasserin (orcid)0000-0001-8142-8284 aut Enthalten in European polymer journal New York, NY [u.a.] : Elsevier, 1965 154 Online-Ressource (DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 nnns volume:154 GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.80 Makromolekulare Chemie AR 154 |
allfieldsSound |
10.1016/j.eurpolymj.2021.110540 doi (DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 DE-627 ger DE-627 rda eng 670 DE-600 35.80 bkl Moramkar, Nimish verfasserin (orcid)0000-0002-0227-9856 aut Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging Bhatt, Purvi verfasserin (orcid)0000-0001-8142-8284 aut Enthalten in European polymer journal New York, NY [u.a.] : Elsevier, 1965 154 Online-Ressource (DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 nnns volume:154 GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.80 Makromolekulare Chemie AR 154 |
language |
English |
source |
Enthalten in European polymer journal 154 volume:154 |
sourceStr |
Enthalten in European polymer journal 154 volume:154 |
format_phy_str_mv |
Article |
bklname |
Makromolekulare Chemie |
institution |
findex.gbv.de |
topic_facet |
Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging |
dewey-raw |
670 |
isfreeaccess_bool |
false |
container_title |
European polymer journal |
authorswithroles_txt_mv |
Moramkar, Nimish @@aut@@ Bhatt, Purvi @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
300897375 |
dewey-sort |
3670 |
id |
ELV006202462 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV006202462</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231205154444.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eurpolymj.2021.110540</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV006202462</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0014-3057(21)00274-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moramkar, Nimish</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-0227-9856</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan derivatives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan nanocomplexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer, optical imaging</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhatt, Purvi</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0001-8142-8284</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">European polymer journal</subfield><subfield code="d">New York, NY [u.a.] : Elsevier, 1965</subfield><subfield code="g">154</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)300897375</subfield><subfield code="w">(DE-600)1483529-0</subfield><subfield code="w">(DE-576)259270830</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2411</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield></datafield></record></collection>
|
author |
Moramkar, Nimish |
spellingShingle |
Moramkar, Nimish ddc 670 bkl 35.80 misc Chitosan derivatives misc Chitosan nanoparticles misc Chitosan nanocomplexes misc Drug delivery misc Cancer, optical imaging Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
authorStr |
Moramkar, Nimish |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)300897375 |
format |
electronic Article |
dewey-ones |
670 - Manufacturing |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
670 DE-600 35.80 bkl Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging Chitosan derivatives Chitosan nanoparticles Chitosan nanocomplexes Drug delivery Cancer, optical imaging |
topic |
ddc 670 bkl 35.80 misc Chitosan derivatives misc Chitosan nanoparticles misc Chitosan nanocomplexes misc Drug delivery misc Cancer, optical imaging |
topic_unstemmed |
ddc 670 bkl 35.80 misc Chitosan derivatives misc Chitosan nanoparticles misc Chitosan nanocomplexes misc Drug delivery misc Cancer, optical imaging |
topic_browse |
ddc 670 bkl 35.80 misc Chitosan derivatives misc Chitosan nanoparticles misc Chitosan nanocomplexes misc Drug delivery misc Cancer, optical imaging |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
European polymer journal |
hierarchy_parent_id |
300897375 |
dewey-tens |
670 - Manufacturing |
hierarchy_top_title |
European polymer journal |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)300897375 (DE-600)1483529-0 (DE-576)259270830 |
title |
Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
ctrlnum |
(DE-627)ELV006202462 (ELSEVIER)S0014-3057(21)00274-3 |
title_full |
Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
author_sort |
Moramkar, Nimish |
journal |
European polymer journal |
journalStr |
European polymer journal |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
zzz |
author_browse |
Moramkar, Nimish Bhatt, Purvi |
container_volume |
154 |
class |
670 DE-600 35.80 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Moramkar, Nimish |
doi_str_mv |
10.1016/j.eurpolymj.2021.110540 |
normlink |
(ORCID)0000-0002-0227-9856 (ORCID)0000-0001-8142-8284 |
normlink_prefix_str_mv |
(orcid)0000-0002-0227-9856 (orcid)0000-0001-8142-8284 |
dewey-full |
670 |
author2-role |
verfasserin |
title_sort |
insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
title_auth |
Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
abstract |
Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. |
abstractGer |
Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. |
abstract_unstemmed |
Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery. |
collection_details |
GBV_USEFLAG_U SYSFLAG_U GBV_ELV GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2411 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 |
title_short |
Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging |
remote_bool |
true |
author2 |
Bhatt, Purvi |
author2Str |
Bhatt, Purvi |
ppnlink |
300897375 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.eurpolymj.2021.110540 |
up_date |
2024-07-06T20:34:27.720Z |
_version_ |
1803863266659663872 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV006202462</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231205154444.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eurpolymj.2021.110540</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV006202462</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0014-3057(21)00274-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moramkar, Nimish</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-0227-9856</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cancer is a multifactorial, unpredictable chronic ailment with an anarchical, uncontrolled cell proliferation and globally is one of the leading causes of mortality and morbidity owing to limitations in effectual theranostics (detection and therapy). Current treatment modalities include chemo and radiation therapy, surgery and targeted therapies which are expensive and often accompanied by undesirable outcomes. Nanotechnology has remarkably and briskly emerged in the past few decades and developed target specific drug carriers for delivery of therapeutic molecules for tumor theranostics. Chitosan (CS) based nanocomplexes have synergistically evolved as potential drug delivery vectors with biocompatibility, biodegradability, negligible toxicity, structural changeability and used to dispatch therapeutic agents to tumor cells via targeted approach and help evade issues challenged by drug delivery thereby ameliorating treatment efficiency. This review provides insight into physicochemical attributes of CS derivatives, compares their advantages/ limitations and use of CS-based derivatives for their diverse biomedical and pharmaceutical applications such as cancer diagnosis, imaging, photodynamic therapy and drug/nano-vaccine delivery.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan derivatives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chitosan nanocomplexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer, optical imaging</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhatt, Purvi</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0001-8142-8284</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">European polymer journal</subfield><subfield code="d">New York, NY [u.a.] : Elsevier, 1965</subfield><subfield code="g">154</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)300897375</subfield><subfield code="w">(DE-600)1483529-0</subfield><subfield code="w">(DE-576)259270830</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2411</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield></datafield></record></collection>
|
score |
7.400571 |